Vol 3, No 2 (2017)
Review paper
Published online: 2017-06-20

open access

Page views 1074
Article views/downloads 1936
Get Citation

Connect on Social Media

Connect on Social Media

Kacheksja reumatoidalna

Magdalena Krajewska-Włodarczyk, Włodzimierz Samborski
Forum Reumatol 2017;3(2):65-71.

Abstract

Wyniszczenie jest wynikiem długotrwałego złożonego procesu patologicznego, w którym dochodzi do utraty tkanki mięśniowej, tłuszczowej i kostnej. Konsekwencją ubytku masy mięśniowej jest osłabienie siły mięśniowej i sprawności fizycznej, prowadząc do wzrostu ryzyka upadków co przy ubytku tkanki kostnej prowadzi do wzrostu ryzyka złamań i ich powikłań. Obecnie nie jest znany mechanizm prowadzący do wyniszczenia, ale zwraca się dodatkowo uwagę na wzrost spoczynkowego wydatku energetycznego, wzmożony katabolizm białkowy oraz nadprodukcję cytokin prozapalnych. Kacheksja w reumatoidalnym zapaleniu stawów uważana jest za czynnik pogarszający rokowanie zarówno co do przebiegu choroby, jak i przeżycia. Nie ma dotychczas opracowanych standardów postępowania leczniczego w kacheksji reumatoidalnej. Ćwiczenia wytrzymałościowe i siłowe, dostosowane do aktualnego stanu chorych, wydają się najbardziej skuteczną metodą zapobiegania utracie masy mięśniowej, natomiast wyniszczenie w przebiegu reumatologicznego zapalenia stawów wydaje się być oporne na terapię żywieniową i rozwija się nawet wobec prawidłowo zbilansowanej diety.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Paget J. Nervous mimicry of organic diseases. Lancet. 1873; 2: 727–9.
  2. Roubenoff R, Roubenoff RA, Ward LM, et al. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol. 1992; 19(10): 1505–1510.
  3. Kotler DP. Cachexia. Ann Intern Med. 2000; 133(8): 622–634.
  4. Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008; 27(6): 793–799.
  5. Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29(2): 154–159.
  6. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4): 412–423.
  7. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Composition of the ESPEN Working Group. Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr. 2004; 23(5): 1226–1243.
  8. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging. 2009; 13(8): 724–728.
  9. Svenson KL, Pollare T, Lithell H, et al. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism. 1988; 37(2): 125–130.
  10. Chung CP, Oeser A, Solus JF, et al. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008; 58(7): 2105–2112.
  11. Engvall IL, Elkan AC, Tengstrand B, et al. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol. 2008; 37(5): 321–328.
  12. Elkan AC, Engvall IL, Cederholm T, et al. Malnutrition in women with rheumatoid arthritis is not revealed by clinical anthropometrical measurements or nutritional evaluation tools. Eur J Clin Nutr. 2008; 62(10): 1239–1247.
  13. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994; 93(6): 2379–2386.
  14. Rall LC, Rosen CJ, Dolnikowski G, et al. Protein metabolism and its mediators before and after strength training in aging and chronic inflammation. Arthritis Rheum. 1996; 39: 1115–24.
  15. Arshad A, Rashid R, Benjamin K. The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism. Mod Rheumatol. 2007; 17(6): 470–475.
  16. Roubenoff R, Walsmith J, Lundgren N, et al. Low physical activity reduces total energy expenditure in women with rheumatoid arthritis: implications for dietary intake recommendations. Am J Clin Nutr. 2002; 76(4): 774–779.
  17. Binymin K, Herrick Al, Carlson Gl, et al. The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis. J Inflamm Res. 2011; 4: 61–66.
  18. Henchoz Y, Bastardot F, Guessous I, et al. Physical activity and energy expenditure in rheumatoid arthritis patients and matched controls. Rheumatology (Oxford). 2012; 51(8): 1500–1507.
  19. Morley JE, Thomas DR, Wilson MMG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006; 83(4): 735–743.
  20. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford). 2004; 43(10): 1219–1223.
  21. Walsmith J, Abad L, Kehayias J, et al. Cachexia in rheumatoid arthritis. Int J Cardiol. 2002; 85(1): 89–99.
  22. van Bokhorst-de van der Schueren MAE, Konijn NPC, Bultink IEM, et al. Relevance of the new pre-cachexia and cachexia definitions for patients with rheumatoid arthritis. Clin Nutr. 2012; 31(6): 1008–1010.
  23. Morley JE, Thomas DR, Wilson MMG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006; 83(4): 735–743.
  24. Rall LC, Walsmith JM, Snydman L, et al. Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion. Arthritis Rheum. 2002; 46(10): 2574–2577.
  25. Ibañez De Cáceres I, Villanúa MA, Soto L, et al. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone. J Endocrinol. 2000; 165(3): 537–544.
  26. López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013; 153(6): 1194–1217.
  27. Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008; 197(1): 1–10.
  28. Rall LC, Meydani SN, Kehayias JJ, et al. The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthritis Rheum. 1996; 39(3): 415–426.
  29. Roubenoff R, Roubenoff RA, Ward LM, et al. Catabolic effects of high-dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis. Am J Clin Nutr. 1990; 52(6): 1113–1117.
  30. Marcora SM, Lemmey AB, Maddison PJ. Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study. J Rheumatol. 2005; 32(6): 1031–1039.
  31. Marcora SM, Chester KR, Mittal G, et al. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr. 2006; 84(6): 1463–1472.
  32. Marcora S, Lemmey A, Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr. 2005; 24(3): 442–454.
  33. Koutedakis Y, Begum S, Labib M, et al. Causes of cachexia in rheumatoid arthritis. Br J Rheumatol. 1996; 35: 200.
  34. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KMJ, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford). 2007; 46(12): 1824–1827.
  35. Metsios GS, Stavropoulos-Kalinoglou A, Nevill AM, et al. Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis. Ann Rheum Dis. 2008; 67(1): 70–73.
  36. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis. 2007; 66(10): 1316–1321.
  37. Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis. 1997; 56(5): 326–329.
  38. Helliwell M, Coombes EJ, Moody BJ, et al. Nutritional status in patients with rheumatoid arthritis. Ann Rheum Dis. 1984; 43(3): 386–390.
  39. Kennedy AC, Boddy K, Williams ED, et al. Whole body elemental composition during drug treatment of rheumatoid arthritis: a preliminary study. Ann Rheum Dis. 1979; 38(2): 137–140.
  40. Helliwell PS, Jackson S. Relationship between weakness and muscle wasting in rheumatoid arthritis. Ann Rheum Dis. 1994; 53(11): 726–728.
  41. Mody GM, Brown GM, Meyers OL, et al. Nutritional assessment in rheumatoid arthritis. S Afr Med J. 1989; 76(6): 255–257.
  42. Haugen M, Homme KA, Reigstad A, et al. Assessment of nutritional status in patients with rheumatoid arthritis and osteoarthritis undergoing joint replacement surgery. Arthritis Care Res. 1999; 12(1): 26–32.
  43. Toussirot E, Nguyen NU, Dumoulin G, et al. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford). 2005; 44(1): 120–125.
  44. Westhovens R, Nijs J, Taelman V, et al. Body composition in rheumatoid arthritis. Br J Rheumatol. 1997; 36(4): 444–448.
  45. Blackman MR, Muniyappa R, Wilson M, et al. Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study. Arthritis Res Ther. 2007; 9(4): R73.
  46. Sahin G, Guler H, Incel N, et al. Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis? Int J Fertil Womens Med. 2006; 51(2): 70–74.
  47. Shibuya K, Hagino H, Morio Y, et al. Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol. 2002; 21(2): 150–158.
  48. Wallace LS, Ballard JE, Holiday DB, et al. Comparison between 60 matched pairs of postmenopausal black and white women: analysis of risk factors related to bone mineral density. Maturitas. 2005; 52(3-4): 356–363.
  49. Häkkinen A, Pakarinen A, Hannonen P, et al. Effects of prolonged combined strength and endurance training on physical fitness, body composition and serum hormones in women with rheumatoid arthritis and in healthy controls. Clin Exp Rheumatol. 2005; 23(4): 505–512.
  50. Sambrook PN, Spector TD, Seeman E, et al. Osteoporosis in rheumatoid arthritis. A monozygotic co-twin control study. Arthritis Rheum. 1995; 38(6): 806–809.
  51. Madsen OR, Egsmose C, Hansen B, et al. Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis. Clin Exp Rheumatol. 1998; 16(1): 27–32.
  52. Kalla AA, Brown G, Meyers OL. Nutritional status in rheumatoid arthritis. Effects of disease activity, corticosteroid therapy and functional impairment. S. Afr. Med. J. 1992; 82: 411–44.
  53. Inaba M, Tanaka K, Goto H, et al. Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. J Rheumatol. 2007; 34(2): 290–295.
  54. Hernandez-Beriain JA, Segura-Garcia C, Rodriguez-Lozano B, et al. Undernutrition in rheumatoid arthritis patients with disability. Scand J Rheumatol. 1996; 25(6): 383–387.
  55. Fukuda W, Yamazaki T, Akaogi T, et al. Malnutrition and disease progression in patients with rheumatoid arthritis. Mod Rheumatol. 2005; 15(2): 104–107.
  56. Engelhart M, Kondrup J, Høie LH, et al. Weight reduction in obese patients with rheumatoid arthritis, with preservation of body cell mass and improvement of physical fitness. Clin Exp Rheumatol. 1996; 14(3): 289–293.
  57. Ellis KJ. Human body composition: in vivo methods. Physiol Rev. 2000; 80(2): 649–680.
  58. Elkan AC, Håkansson N, Frostegård J, et al. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2009; 11(2): R37.
  59. B. A. Resistance Training for Patients with Rheumatoid Arthritis: Effects on Disability, Rheumatoid Cachexia, and Osteoporosis; and Recommendations for Prescription. Rheumatoid Arthritis - Treatment. 2012.
  60. Dessein PH, Joffe BI, Stanwix AE. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study. Arthritis Res. 2002; 4(6): R12.
  61. Ferraz-Amaro I, González-Juanatey C, López-Mejias R, et al. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm. 2013; 2013: 710928.
  62. Elkan AC, Engvall IL, Cederholm T, et al. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr. 2009; 48(5): 315–322.
  63. Chen CY, Tsai CY, Lee PC, et al. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin. Curr Pharm Des. 2013; 19(10): 1956–1964.
  64. Hurkmans E, van der Giesen FJ, Vliet Vlieland TPm, et al. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev. 2009(4): CD006853.
  65. Sharif S, Thomas JM, Donley DA, et al. Resistance exercise reduces skeletal muscle cachexia and improves muscle function in rheumatoid arthritis. Case Rep Med. 2011; 2011: 205691.
  66. Baillet A, Vaillant M, Guinot M, et al. Efficacy of resistance exercises in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology (Oxford). 2012; 51(3): 519–527.
  67. Mikkelsen UR, Couppé C, Karlsen A, et al. Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size. Mech Ageing Dev. 2013; 134(11-12): 531–540.